Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 1995 pfu; rubella virus, quantity: 1000 ccid50; measles virus, quantity: 1000 ccid50; mumps virus, quantity: 25119 ccid50 - diluent, not applicable - excipient ingredients: water for injections - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella from 9 months of age.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - measles virus, quantity: 1000 ccid50; rubella virus, quantity: 1000 ccid50; mumps virus, quantity: 25119 ccid50; live varicella vaccine, quantity: 1995 pfu - diluent, not applicable - excipient ingredients: water for injections - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella from 9 months of age.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rubella virus, quantity: 1000 ccid50; mumps virus, quantity: 25119 ccid50; measles virus, quantity: 1000 ccid50; live varicella vaccine, quantity: 1995 pfu - injection, powder for - excipient ingredients: mannitol; sorbitol; lactose; threonine; serine; proline; glycine; alanine; valine; methionine; isoleucine; leucine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella from 9 months of age.

Malta - angličtina - Malta Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - powder and solvent for solution for injection in pre-filled syringe - varicella virus oka strain (live, attenuated) 10pfu/dose - vaccines

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - varicella virus (oka strain) live attenuated - powder and solvent for suspension for injection - =1350 plaque forming unit - varicella, live attenuated

Singapur - angličtina - HSA (Health Sciences Authority)

unison collaborative pte. ltd. - immunology - the serion elisa classic varicella-zoster virus igg test is qualitative and quantitative immunoassay for the detection of human antibodies directed against varicella zoster virus in serum or plasma. the demonstration of igg antibodies directed against the vzv glycoprotein allows for the determination of the immune status. the serion elisa classic varicella zoster virus igg test allows for the demonstration of intrathecally synthesized antibodies in csf diagnostics.

Singapur - angličtina - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the virgo varicella-zoster virus igg indirect fluorescent antibody (ifa) test is intended for the detection and titration of antibodies to varicella-zoster virus in human sera.

Malajzia - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - varicella, live attenuated -

Singapur - angličtina - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - varicella zoster virus (live attenuated) (oka strain) - injection, powder, for solution - varicella zoster virus (live attenuated) (oka strain) min 2000 pfu

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - varicella vaccine 1350 pfu (oka/merck);   - injection with diluent - 1350 pfu - active: varicella vaccine 1350 pfu (oka/merck)   excipient: dibasic sodium phosphate dodecahydrate gelatin monobasic potassium phosphate monosodium glutamate potassium chloride sodium chloride sucrose urea water for injection - varivax is indicated for vaccination against varicella in individuals 12 months of age and older.